Having Medication Is Not the Same as Taking Medication

Thoughts on the WSJ article "Pharmacies Flood Medicare Patients With $3 Billion of Extra Drugs" — December 26, 2025

We've gotten remarkably good at getting medications to the doorstep. Mail order, same-day delivery, auto-refills — logistics are no longer the hard part.

But there's an uncomfortable truth hiding in plain sight: having medication is not the same as taking medication. The Wall Street Journal recently documented how automated refill systems can lead to patients accumulating piles of extra pills — sometimes refills arriving before prior supplies are finished — creating confusion, waste, and real safety risk.

That gap — delivery vs. ingestion — is where outcomes are won or lost. Or as Dr. Everett Koop, former U.S. Surgeon General put it: "For meds to work, people actually have to take them."

When Convenience Becomes Complexity

When medications show up early, duplicate, or in large quantities, patients don't experience "convenience" — they experience complexity. More bottles, more dates, more chances to miss doses, double dose, or abandon a regimen entirely. The WSJ reporting underscored what clinicians see every day: surplus pills can increase confusion and medication errors, especially for people managing multiple prescriptions.

RedCap: From "A Bottle on the Counter" to a Simple Daily System

RedCap flips the experience from "a bottle on the counter" to a simple daily system:

From a Distribution Mindset to an Outcomes Mindset

This matters because adherence is not a niche problem. Across chronic conditions, research has long found that adherence commonly averages around ~50% — meaning even "great" drugs often don't deliver real-world results.

For pharmacies, manufacturers, payers, and providers, the industry's default response to nonadherence has often been more outreach, more reminders, more shipping. But the WSJ story illustrates a core failure mode: systems can optimize for "medication possession" while patients still don't take the meds.

RedCap helps companies move from a distribution mindset to an outcomes mindset:

• Better real-world effectiveness: When patients take therapies as prescribed, clinical value shows up in actual lives — not just trial data.
• Stronger trust and retention: Patients don't quit brands — they quit confusing regimens. RedCap reduces friction, which reduces drop-off.
• Lower avoidable costs: When adherence improves, downstream costs from complications and preventable escalations fall — benefiting every stakeholder exposed to total cost of care.

The Ripple Effect of Non-Adherence

Medication nonadherence doesn't just hurt the individual patient — it creates a ripple effect: more complications, more avoidable acute events, more wasted medication, more strain on caregivers and clinicians.

And when extra medication accumulates, society inherits additional risks — diversion, unsafe storage, and disposal problems — on top of pure financial waste. The WSJ reporting on surplus shipments highlights how quickly "convenience" can turn into a public-health and system-efficiency problem.